Stocktoria
Trevi Therapeutics, Inc. TRVI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-05-07
Trevi Therapeutics, Inc. statistics & valuation
Market cap$2.6B
P / B14.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -22.1% | -43.2% | -32.5% | -23.7% | -88.2% |
| Return on equity | -23.3% | -48.1% | -35.2% | -27.1% | -198.8% |
| Current ratio | 19.66 | 10.41 | 15.03 | 9.15 | 2.98 |
Source: SEC EDGAR filings · CIK 0001563880 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.